Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 4 July

Sophia Mavridis
July 4, 2023

Morning Bell 3 July

Grady Wulff
July 3, 2023

Weekly Wrap 30 June

Grady Wulff
June 30, 2023

Morning Bell 30 June

Sophia Mavridis
June 30, 2023

Morning Bell 29 June

Grady Wulff
June 29, 2023

Morning Bell 28 June

Grady Wulff
June 28, 2023

Morning Bell 27 June

Grady Wulff
June 27, 2023

Morning Bell 26 June

Grady Wulff
June 26, 2023

Weekly Wrap 23 June

Grady Wulff
June 23, 2023

Morning Bell 23 June

Sophia Mavridis
June 23, 2023

Morning Bell 22 June

Sophia Mavridis
June 22, 2023

Morning Bell 21 June

Grady Wulff
June 21, 2023